Christopher Scully has been appointed executive vice president and chief financial officer, Pharmaceutical Product Development, LLC. Mr. Scully has more than 25 years of experience and extensive financial and commercial expertise in the pharmaceutical industry. He will be based in PPD’s headquarters in Wilmington.
 
“Chris has a broad depth of knowledge and experience in the life sciences industry that comes from serving in senior financial and general manager roles with large pharma,” said David Simmons, PPD’s chairman and chief executive officer. “His unique blend of experience will complement and support our focus on delivering our mission, as well as superior financial results. I am confident Chris is well-suited to PPD’s culture as a company committed to integrity, financial discipline and sustainable growth.”
 
Most recently, Mr. Scully served as chief commercial officer for Pfizer’s essential health business unit where he led efforts to transform the $26 billion unit into a sustainably growing business with industry-leading franchises in multiple market segments. During his 21 years with Pfizer, he helped grow and transform several multibillion-dollar businesses through a variety of senior roles, including: regional president, established products Europe; vice president of finance/CFO, established products business unit; and vice president of finance, both for Japan and Asia and then for Pfizer’s worldwide pharmaceutical business.